Morris Levin, MD
Neurology · San Francisco, CANPI 1538117403
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Lilly USA, LLC at 25.2% of the total. 2024 is the largest year on record at $9,929, 2.9 times the $3,451 reported in 2019.
Across 32 payments — averaging $818.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$7K
- AbbVie$3K
- Biodelivery Sciences International, Inc.$3K
- Amneal Pharmaceuticals LLC$3K
- Supernus Pharmaceuticals, Inc.$3K
- Biohaven Pharmaceuticals, Inc.$3K
- plus $5K from 4 others
What the payments were for
- Consulting fees$11,03842%
- Speaking & faculty fees$13,56352%
- Travel & lodging$6022%
- Food & beverage$9834%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 3 | $6,593 |
| AbbVie(2 entities) | 9 | $3,472 |
| Biodelivery Sciences International, Inc. | 1 | $3,000 |
| Amneal Pharmaceuticals LLC | 3 | $2,950 |
| Supernus Pharmaceuticals, Inc. | 6 | $2,842 |
| Biohaven Pharmaceuticals, Inc. | 2 | $2,625 |
| Upsher-smith Laboratories LLC | 2 | $2,398 |
| Currax Pharmaceuticals LLC | 3 | $2,151 |
| Novartis | 2 | $122 |
| Lundbeck LLC | 1 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMGALITY$6,563
- ELYXYB - CELECOXIB$3,000
- TROKENDI XR$2,664
- NURTEC ODT$2,625
- Zembrace SymTouch Sumatriptan Injection$2,398
- Tosymra Sumatriptan Nasal Spray$2,398
- ONZETRA XSAIL$2,000
- BOTOX$1,788
- QULIPTA$1,300
- UBRELVY$325
How this compares
$26,185 in reported general payments places this provider in the 85th percentile of 1,996 neurology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in San Francisco
- S Claiborne JohnstonSan Francisco$576K
- Armen MoughamianSan Francisco$554K
- Scott ZamvilSan Francisco$447K
- Bruce CreeSan Francisco$412K
- Kenneth LaxerSan Francisco$379K
- Jonathan KatzSan Francisco$294K
- Nada HindiyehSan Francisco$268K
- Douglas GoodinSan Francisco$227K
- Andrew BlumenfeldCarlsbad$4.9M
- Khashayar DashtipourLoma Linda$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.